Laura Koth

Co-Director, UCSF Interstitial Lung Disease Center of Excellence · UCSF Health - Family Medicine Lakeshore

Credentials: · · · ·

History

Development of Clinical Prediction Models for Pulmonary Outcomes in Sarcoidosis: Vitamin D Metabolism
National Heart, Lung, and Blood Institute · R01
Contact PI · $5.6M · University of California, San Francisco
2022–2030
A Prospective Study of T Cell Immune-Phenotype and Disease Outcome in Pulmonary Sarcoidosis
National Heart, Lung, and Blood Institute · R01
PI · $4M · National Jewish Health
2018–2023
Interferon Gamma-Producing Th17 Subsets: Major Contributors to "Th1" Diseases
National Institute of Allergy and Infectious Diseases · R03
Contact PI · $158.5K · University of California, San Francisco
2016–2018
Genomic Phenotyping and Mechanisms in Sarcoidosis and AAT
National Heart, Lung, and Blood Institute · U01
Contact PI · $469.6K · University of California, San Francisco
2012–2016

Risk Indicators of Sarcoidosis Evolution-Unified Protocol
Principal investigator · Recruiting
University of California, San Francisco
2023–2030
Use of CXCL9 as a Biomarker of Acthar Efficacy
Principal investigator · Terminated · Phase 4
University of California, San Francisco
2022–2025
Ancillary T Cell Based Studies in SPIROMICS
Principal investigator · Completed
University of California, San Francisco
2012–2016